|
122 Companies |
|
195 Products |
|
195 Products |
|
116 Mechanisms of Action |
|
3 Trials |
|
2333 News |
|
| «12...1617181920212223242526...4647» |
- Enrollment open, Trial initiation date, Trial primary completion date: Effects of a NeuroAD System, for the Treatment of Alzheimer Disease (clinicaltrials.gov) - Dec 10, 2014
P=N/A, N=40, Recruiting, Sponsor: Neuronix Ltd
Not yet recruiting --> Recruiting | Initiation date: Aug 2014 --> Nov 2014 | Trial primary completion date: Aug 2016 --> Nov 2016
- Trial completion, Enrollment change: CogEx: Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple Sclerosis (clinicaltrials.gov) - Dec 10, 2014
P1/2, N=35, Completed, Sponsor: University of California, Los Angeles
Not yet recruiting --> Recruiting | Initiation date: Aug 2014 --> Nov 2014 | Trial primary completion date: Aug 2016 --> Nov 2016 Active, not recruiting --> Completed | N=50 --> 35
- ||| encenicline (EVP-6124) / Forum Pharmaceuticals, Mitsubishi Tanabe
Trial initiation date: Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine (clinicaltrials.gov) - Dec 10, 2014
P2, N=150, Not yet recruiting, Sponsor: FORUM Pharmaceuticals Inc
Active, not recruiting --> Completed | N=50 --> 35 Initiation date: Oct 2014 --> Jul 2015
- Biomarker: PACE-2: Piedmont Aging, Cognition & Exercise Study-2 (clinicaltrials.gov) - Dec 10, 2014
P=N/A, N=40, Recruiting, Sponsor: Wake Forest School of Medicine
- Enrollment closed: Cognitive Intervention For Delirium in Dementia (clinicaltrials.gov) - Dec 9, 2014
P2, N=256, Active, not recruiting, Sponsor: Penn State University
Initiation date: Oct 2014 --> Jul 2015 Recruiting --> Active, not recruiting
- Trial primary completion date: 2CARE: Coenzyme Q10 in Huntington's Disease (HD) (clinicaltrials.gov) - Dec 7, 2014
P3, N=608, Active, not recruiting, Sponsor: Massachusetts General Hospital
Recruiting --> Active, not recruiting Trial primary completion date: Aug 2017 --> Aug 2015
- ||| Trial completion, Trial primary completion date: A Rehabilitation Intervention for Amnestic Mild Cognitive Impairment (clinicaltrials.gov) - Dec 7, 2014
P=N/A, N=128, Completed, Sponsor: Emory University
Trial primary completion date: Aug 2017 --> Aug 2015 Active, not recruiting --> Completed | Trial primary completion date: Apr 2014 --> Aug 2013
- Trial completion, Enrollment change: The HIP-HOP Flooring Study: Helping Injury Prevention in Hospitalised Older People (clinicaltrials.gov) - Dec 7, 2014
P=N/A, N=571, Completed, Sponsor: University of Portsmouth
Active, not recruiting --> Completed | Trial primary completion date: Apr 2014 --> Aug 2013 Enrolling by invitation --> Completed | N=800 --> 571
- Enrollment open, Trial initiation date, Trial primary completion date, Metastases: The Preventative Role of Exogenous Melatonin Administration in Patients With Advanced Cancer Who Are at Risk of Delirium: a Feasibility Study (clinicaltrials.gov) - Dec 6, 2014
P2, N=60, Recruiting, Sponsor: Bruyere Research Institute
Enrolling by invitation --> Completed | N=800 --> 571 Not yet recruiting --> Recruiting | Initiation date: Sep 2014 --> Dec 2014 | Trial primary completion date: May 2015 --> Aug 2015
- Enrollment closed, Trial primary completion date: 4-question "RACY" Delirium Screening Tool Validation Study (clinicaltrials.gov) - Dec 6, 2014
P=N/A, N=1093, Active, not recruiting, Sponsor: University of Cape Town
Not yet recruiting --> Recruiting | Initiation date: Sep 2014 --> Dec 2014 | Trial primary completion date: May 2015 --> Aug 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2014 --> May 2014
- ||| Clinical: How Beta-amyloid Imagining Influences Clinician Diagnosis and Management of Hypothetical Patients With Cognitive Complaints (clinicaltrials.gov) - Dec 6, 2014
P=N/A, N=315, Completed, Sponsor: Tufts Medical Center
- Trial completion: Impact of Grape Consumption on Brain Metabolism and Cognitive Function (clinicaltrials.gov) - Dec 6, 2014
P1, N=12, Completed, Sponsor: University of California, Los Angeles
Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2014 --> May 2014 Recruiting --> Completed
- Trial primary completion date: Impact of Exercise on Cognitive Impairment in End-Stage Renal Disease (clinicaltrials.gov) - Dec 5, 2014
P=N/A, N=15, Recruiting, Sponsor: University of Kansas
Recruiting --> Completed Trial primary completion date: May 2015 --> Dec 2015
- donepezil / Generic mfg.
Enrollment open, Trial primary completion date: Treatment of Delirium in the Elderly With Donepezil: a Double-blind, Randomized, Placebo-controlled Clinical Trial (clinicaltrials.gov) - Dec 5, 2014
P4, N=190, Recruiting, Sponsor: University of Sao Paulo
Trial primary completion date: May 2015 --> Dec 2015 Not yet recruiting --> Recruiting | Trial primary completion date: Aug 2014 --> Aug 2016
- || Enrollment closed, Trial primary completion date, Patient reported outcomes: CIAS PRO: Schizophrenia Cognition Scale Development (clinicaltrials.gov) - Dec 5, 2014
P=N/A, N=125, Active, not recruiting, Sponsor: New England Research Institutes
Not yet recruiting --> Recruiting | Trial primary completion date: Aug 2014 --> Aug 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2014 --> Jan 2015
- || Enrollment closed: Two Interventions for Early Stage Dementia: A Comparative Efficacy Trial (clinicaltrials.gov) - Dec 5, 2014
P=N/A, N=240, Active, not recruiting, Sponsor: University of Washington
Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2014 --> Jan 2015 Recruiting --> Active, not recruiting
- | Trial completion, HEOR: ADEX: Effect of Physical Exercise in Alzheimer Patients (clinicaltrials.gov) - Dec 5, 2014
P3, N=200, Completed, Sponsor: Rigshospitalet, Denmark
Recruiting --> Active, not recruiting Recruiting --> Completed
- Trial completion, Enrollment change, Trial primary completion date: Physical Exercise as an Additional Treatment for Alzheimer Disease (clinicaltrials.gov) - Dec 5, 2014
P=N/A, N=20, Completed, Sponsor: Universidade Federal do Rio de Janeiro
Recruiting --> Completed Recruiting --> Completed | N=60 --> 20 | Trial primary completion date: Jun 2011 --> Jun 2013
- Trial completion, Enrollment change, Trial primary completion date: Delirium in Mechanically Ventilated Patients (clinicaltrials.gov) - Dec 5, 2014
P=N/A, N=102, Completed, Sponsor: University of Chicago
Recruiting --> Completed | N=60 --> 20 | Trial primary completion date: Jun 2011 --> Jun 2013 Recruiting --> Completed | N=150 --> 102 | Trial primary completion date: Nov 2014 --> Oct 2013
- fluoxetine / Generic mfg.
Trial initiation date: Fluoxetine Prevention Trial (clinicaltrials.gov) - Dec 5, 2014
P=N/A, N=376, Not yet recruiting, Sponsor: University of California, Los Angeles
Recruiting --> Completed | N=150 --> 102 | Trial primary completion date: Nov 2014 --> Oct 2013 Initiation date: Oct 2012 --> Jun 2015
- dexmedetomidine / Generic mfg.
Surgery: Efficacy of Single-Shot Dexmedetomidine Versus Placebo in Preventing Pediatric Emergence Delirium in Strabismus Surgery (clinicaltrials.gov) - Dec 5, 2014
P4, N=132, Active, not recruiting, Sponsor: New York University School of Medicine
Initiation date: Oct 2012 --> Jun 2015 Recruiting --> Active, not recruiting
- || Enrollment closed, Metastases: Goals of Care: A Nursing Home Trial of Decision Support for Advanced Dementia (clinicaltrials.gov) - Dec 5, 2014
P=N/A, N=300, Active, not recruiting, Sponsor: University of North Carolina, Chapel Hill
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Tasigna (nilotinib) / Novartis, Inhibikase
Enrollment open: Nilotinib in Cognitively Impaired Parkinson Disease Patients 001 (clinicaltrials.gov) - Dec 3, 2014
P1, N=36, Recruiting, Sponsor: Georgetown University
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- Biomarker: LIDEAL: Relationship Between Protein Biomarkers in Cerebrospinal Fluid and Alzheimer&Apos;s Disease in Patients With Depression (clinicaltrials.gov) - Nov 28, 2014
P=N/A, N=50, Recruiting, Sponsor: Institut Investigacio Sanitaria Pere Virgili
- | Caplyta (lumateperone) - Intra / Cellular Therapies
Trial completion, Enrollment change: Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia (clinicaltrials.gov) - Nov 28, 2014
P1/2, N=35, Completed, Sponsor: Intra-Cellular Therapies, Inc.
Not yet recruiting --> Recruiting Active, not recruiting --> Completed | N=52 --> 35
- sevoflurane / Generic mfg.
Trial completion: Optimization of Desflurane in Elderly Patients (clinicaltrials.gov) - Nov 28, 2014
P1/2, N=20, Completed, Sponsor: Sapporo Medical University
Active, not recruiting --> Completed | N=52 --> 35 Active, not recruiting --> Completed
- Trial primary completion date: Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD (clinicaltrials.gov) - Nov 28, 2014
P=N/A, N=30, Recruiting, Sponsor: Mayo Clinic
Active, not recruiting --> Completed Trial primary completion date: Oct 2014 --> Apr 2015
- Enrollment closed: Pharmacokinetic Study Comparing Topical, Rectal, and Oral Quetiapine (clinicaltrials.gov) - Nov 28, 2014
P=N/A, N=10, Active, not recruiting, Sponsor: Mayo Clinic
Trial primary completion date: Oct 2014 --> Apr 2015 Recruiting --> Active, not recruiting
- ketamine / Generic mfg.
Trial initiation date, Trial primary completion date, Surgery: SPMSQ-E: Ketamine and Changes of the Short Portable Mental Status Questionnaire (clinicaltrials.gov) - Nov 25, 2014
P2, N=80, Completed, Sponsor: Instituto Mexicano del Seguro Social
Recruiting --> Active, not recruiting Initiation date: Jun 2012 --> Jun 2013 | Trial primary completion date: Nov 2012 --> Jan 2014
- | Trial completion, Enrollment change, Trial primary completion date: Assessment and Rehabilitation of Cognitive Impairments in Pediatric Survivors of Cancer (clinicaltrials.gov) - Nov 25, 2014
P=N/A, N=23, Completed, Sponsor: Stanford University
Initiation date: Jun 2012 --> Jun 2013 | Trial primary completion date: Nov 2012 --> Jan 2014 Recruiting --> Completed | N=15 --> 23 | Trial primary completion date: Aug 2014 --> Sep 2012
- Enrollment closed, Trial primary completion date: Efficacy of Ubiquitous SR-based Memory Advancement and Rehabilitation Training (U-SMART) (clinicaltrials.gov) - Nov 24, 2014
P3, N=50, Active, not recruiting, Sponsor: Seoul National University Bundang Hospital
Recruiting --> Completed | N=15 --> 23 | Trial primary completion date: Aug 2014 --> Sep 2012 Recruiting --> Active, not recruiting | Trial primary completion date: May 2013 --> Dec 2014
- Phase classification: HEEBW: Home Evaluation of Exit Barriers in Wandering (clinicaltrials.gov) - Nov 24, 2014
P=N/A, N=19, Completed, Sponsor: Department of Veterans Affairs
Recruiting --> Active, not recruiting | Trial primary completion date: May 2013 --> Dec 2014 Phase classification: P2 --> P=N/A
- Trial primary completion date: Effect of Ginkgo Biloba Special Extract LI 1370 on Dual-tasking in Patients With MCI (clinicaltrials.gov) - Nov 20, 2014
P4, N=50, Active, not recruiting, Sponsor: University Hospital, Basel, Switzerland
Phase classification: P2 --> P=N/A Trial primary completion date: Sep 2014 --> Feb 2015
- ||| Clinical: HIAD: Hearing Instruments in Alzheimer's Disease (clinicaltrials.gov) - Nov 19, 2014
P=N/A, N=120, Recruiting, Sponsor: Phonak AG, Switzerland
- |||||||||| Nine Phase One (mannote sodium) / Shanghai Greenvalley
New P3 trial: An Efficacy and Safety Study of Sodium Oligo-mannurarate (GV-971) Capsule for the Treatment of Alzheimer's Disease (clinicaltrials.gov) - Nov 19, 2014
P3, N=788, Recruiting, Sponsor: Shanghai Greenvalley Pharmaceutical Co., Ltd.
- donepezil / Generic mfg., galantamine hydrobromide / Generic mfg., rivastigmine / Generic mfg.
Enrollment closed: Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease (clinicaltrials.gov) - Nov 19, 2014
P3, N=50, Active, not recruiting, Sponsor: Sunnybrook Health Sciences Centre
Trial primary completion date: Sep 2014 --> Feb 2015 Recruiting --> Active, not recruiting
- ||||||| Austedo (deutetrabenazine) / Teva
Trial completion, Trial primary completion date: First-HD: First Time Use of SD-809 in Huntington Disease (clinicaltrials.gov) - Nov 19, 2014
P3, N=90, Completed, Sponsor: Auspex Pharmaceuticals, Inc.
Recruiting --> Active, not recruiting Recruiting --> Completed | Trial primary completion date: Aug 2014 --> Nov 2014
- Trial completion: Estrogen Use in Protection From Cognitive Decline (clinicaltrials.gov) - Nov 19, 2014
P=N/A, N=71, Completed, Sponsor: Stanford University
Recruiting --> Completed | Trial primary completion date: Aug 2014 --> Nov 2014 Active, not recruiting --> Completed
- Trial primary completion date: 2-StaLi: Cognitive Outcome After Two-stage Liver-Operation (clinicaltrials.gov) - Nov 17, 2014
P=N/A, N=20, Recruiting, Sponsor: Charite University, Berlin, Germany
Active, not recruiting --> Completed Trial primary completion date: Feb 2015 --> Feb 2016
- Clinical: Gray Matters Alzheimer's Disease Prevention Intervention (clinicaltrials.gov) - Nov 14, 2014
P=N/A, N=146, Active, not recruiting, Sponsor: Utah State University
- HTL0009936 / Sosei
New P1 trial: Phase I, Healthy Subject, Safety, Tolerability and Pharmacokinetic Study of an M1 Agonist to Treat Cognitive Impairment (clinicaltrials.gov) - Nov 14, 2014
P1, N=109, Active, not recruiting, Sponsor: Heptares Therapeutics Limited
- Enrollment closed: Oral Health Intervention Pilot Study for Individuals With Memory Problems (clinicaltrials.gov) - Nov 14, 2014
P=N/A, N=5, Active, not recruiting, Sponsor: Duke University
Trial primary completion date: Feb 2015 --> Feb 2016 Recruiting --> Active, not recruiting
- || Enrollment change, Trial primary completion date: Retinal Neurodegenerative Signs in Alzheimer's Diseases (clinicaltrials.gov) - Nov 13, 2014
P=N/A, N=300, Recruiting, Sponsor: University Hospital, Bordeaux
Recruiting --> Active, not recruiting N=450 --> 300 | Trial primary completion date: Jun 2014 --> Jun 2015
- Enrollment closed, Trial primary completion date: OPHELIE-COG: Pre-stroke Cognitive Status and Thrombolytic Therapy (clinicaltrials.gov) - Nov 13, 2014
P=N/A, N=1040, Active, not recruiting, Sponsor: University Hospital, Lille
N=450 --> 300 | Trial primary completion date: Jun 2014 --> Jun 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2013 --> Dec 2014
- dexmedetomidine / Generic mfg.
Surgery: Dexmedetomidine to Prevent Agitation After Free Flap Surgery (clinicaltrials.gov) - Nov 13, 2014
P4, N=80, Completed, Sponsor: Peking University
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2013 --> Dec 2014 Recruiting --> Completed | Trial primary completion date: Dec 2014 --> Nov 2013
- |||| rivastigmine transdermal / Generic mfg.
Trial primary completion date: Rivastigmine in the Management of Delirium (clinicaltrials.gov) - Nov 13, 2014
P3, N=440, Recruiting, Sponsor: Assistance Publique - H
Recruiting --> Completed | Trial primary completion date: Dec 2014 --> Nov 2013 Trial primary completion date: Jun 2014 --> Aug 2015
- | Enrollment closed, Trial primary completion date: Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E) (clinicaltrials.gov) - Nov 12, 2014
P3, N=650, Active, not recruiting, Sponsor: Massachusetts General Hospital
Trial primary completion date: Jun 2014 --> Aug 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2016 --> Dec 2014
- New P1 trial: Transcranial Direct Current Stimulation Effects in Patients With Chronic Consciousness Disorders (clinicaltrials.gov) - Nov 12, 2014
P1, N=10, Recruiting, Sponsor: University Hospital of Ferrara
- Clinical: MAPRCT: Mindful Awareness Program for the Prevention of Dementia: A Randomized Controlled Trial (clinicaltrials.gov) - Nov 10, 2014
P=N/A, N=60, Active, not recruiting, Sponsor: National University, Singapore
- ||| Trial completion, Trial primary completion date: EXDEM: Effects of an Exercise Program for Nursing Home Patients With Dementia (clinicaltrials.gov) - Nov 10, 2014
P=N/A, N=170, Completed, Sponsor: Oslo University College
Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2016 --> Dec 2014 Recruiting --> Completed | Trial primary completion date: Oct 2014 --> Sep 2013